CHRISTEN MONTGOMERY: Open Payments
NPI 1225447519 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$950 in 49 payments from 20 companies in 2025. Trend: 2023 $1,187 · 2024 $1,250 · 2025 $950
Food & beverage: $937Education: $12
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $145 |
| Lilly USA, LLC | 8 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $135 |
| Novo Nordisk Inc | 7 | $117 |
| Gilead Sciences, Inc. | 5 | $92 |
| ABBVIE INC. | 2 | $35 |
| Exact Sciences Corporation | 2 | $27 |
| Teleflex LLC | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Verona Pharma, Inc. | 1 | $23 |
Products named: MOUNJARO, FARXIGA, NURTEC ODT, Ozempic, JARDIANCE, AIRSUPRA, Wegovy, PREVNAR 20.
Industry payments across KY — which companies pay providers there.
